chronic myelogenous leukemia
FDA Approves Bosulif for Pediatric Patients With CML
The FDA approved bosutinib (Bosulif, Pfizer) for pediatric patients 1 year of age and older with chronic phase (CP) ...
SEPTEMBER 28, 2023
Early Evaluation of Response to TKI Rx May Improve CML Outcomes
Denver—In chronic myelogenous leukemia (CML) patients taking a tyrosine kinase inhibitor (TKI), earlier ...
APRIL 30, 2018
Load more